However, inhibition of TLR2 or TLR4 in diabetes exhibited reduced inflammatory responses [48, 50, 77], indicating that TLR2 or TLR4 might mediate HMGB-1-induced inflammation in DN. Here, TLR2 is linked to liver dysplastic nodule.